Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus.
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (June 2024)